Alterity Therapeutics
ATHE
14 hedge funds and large institutions have $623K invested in Alterity Therapeutics in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
244% more capital invested
Capital invested by funds: $181K → $623K (+$442K)
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
40% more funds holding
Funds holding: 10 → 14 (+4)
0% more ownership
Funds ownership: 0% → 0.01% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$90.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$31.8K |
| 3 |
EP
Eudaimonia Partners
Winchester,
Tennessee
|
+$15.9K |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$2.45K |
| 5 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
+$763 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $506K | +$90.5K | +14,240 | +50% |
|
|
2
UBS Group
Zurich,
Switzerland
| $63K | +$31.8K | +5,003 | +1,624% |
|
|
EP
3
Eudaimonia Partners
Winchester,
Tennessee
| $30K | +$15.9K | +2,500 | New |
|
4
Geode Capital Management
Boston,
Massachusetts
| $14K | – | – | – |
|
|
FIA
5
FNY Investment Advisers
New York
| $4K | +$2.45K | +385 | New |
|
6
Wells Fargo
San Francisco,
California
| $3K | – | – | – |
|
|
PAG
7
Private Advisor Group
Morristown,
New Jersey
| $1K | +$286 | +45 | New |
|
|
OIA
8
Optimum Investment Advisors
Chicago,
Illinois
| $1K | +$636 | +100 | New |
|
|
CAN
9
Cetera Advisor Networks
El Segundo,
California
| $1K | +$763 | +120 | New |
|
|
APA
10
American Portfolios Advisors
Holbrook,
New York
| $99 | – | – | – |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| – | +$6 | +1 | New |
|
ATHE Hedge Fund Activity: Q2 2020 in Review
14 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q2 2020, worth a combined $623K — up 244% from $181K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ATHE positions and 2 closed out — a net gain of 4 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $90.5K.
- 14 institutional investors held Alterity Therapeutics (ATHE) as of Q2 2020, up from 10 in Q1 2020.
- Funds reported $623K of Alterity Therapeutics stock for Q2 2020, up 244% quarter-over-quarter.
- 6 funds opened new Alterity Therapeutics positions in Q2 2020 and 2 closed out, a net change of +4 holders.
- The largest Alterity Therapeutics buyer in Q2 2020 was Morgan Stanley, an estimated $90.5K added.
Based on aggregated 13F filings for Q2 2020.